Birgitta Gullstrand
21 – 30 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Stress-induced release of the S100A8/A9 alarmin is elevated in coronary artery disease patients with impaired cortisol response
(
- Contribution to journal › Article
- 2016
-
Mark
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
(
- Contribution to journal › Article
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
-
Mark
IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections
(
- Contribution to journal › Article
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources.
(
- Contribution to journal › Article
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
(
- Contribution to journal › Article